Non-Small Cell Lung Carcinoma Market is expected to reach USD 21.40 Billion by 2033, Driven by a 10% CAGR | FMI

The fight against Non-Small Cell Lung Carcinoma Market, the most common type of lung cancer, is bolstered by a growing market for treatment options. According to a recent analysis, the global NSCLC market is projected to reach a significant USD 21.4 billion by 2033. This reflects a substantial increase from a market value of USD …